Proteomics and syndrome of Chinese medicine

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 12, 2010, Pages 2721-2728

  Lu, Chuan Li ^a   Qv, Xiao Ying ^a   Jiang, Jian Guo ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Chinese medicine; Proteomics; Syndrome; Traditional

Indexed keywords

ARTICLE; CHINA; CHINESE MEDICINE; DIFFERENTIAL DIAGNOSIS; GENERAL ASPECTS OF DISEASE; HUMAN; PROTEOMICS; TONGUE;

CHINA; DIAGNOSIS, DIFFERENTIAL; DISEASE; HUMANS; MEDICINE, CHINESE TRADITIONAL; PROTEOMICS; TONGUE;

EID: 78650053114     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01178.x     Document Type: Article

References (31)

1. Guo L, Wang YY, Zhang ZB, et al. Origination and development of syndrome concept in traditional Chinese medicine. J Chin Integr Med. 2006; 4: 335-8.
2. Zhang B, Wang YY. Research on TCM syndrome nomenclature and classification: review and hypothesis. J Beijing Univ Tradit Chin Med. 2003; 26: 1-5.
3. Scott DP, Ruedi HA. Proteomics: the first decade and beyond. Nat Genet. 2003; 33: 311-23.
4. Rosamonde EB, Michael JD, Denis FH, et al. Proteomics: new perspectives, new biomedical opportunities. Lancet. 2000; 356: 1749-56.
5. Gorg A, Obermaier C, Boguth G, et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis. 2000; 21: 1037-53.
6. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003; 422: 198-207.
7. Dhamoon AS, Kohn EC, Azad NS. The ongoing evolution of proteomics in malignancy. Drug Discov Today. 2007; 12: 700-8.
8. Sheng P, Ruedi A, Ru C, et al. Mass spectrometry based targeted protein quantification: methods and applications. J Proteome Res. 2009; 8: 787-9.
9. Brichory F, Beer D, Naour FL, et al. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res. 2001; 61: 7908-12.
10. Petricoin EF, Zoon KC, Kohn EC, et al. Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov. 2002; 1: 683-95.
11. Julia DW, Dennis CS, Henry K, et al. Proteomics of human breast ductal carcinoma in situ. Cancer Res. 2002; 62: 6740-9.
12. Sam H. Disease proteomics. Nature. 2003; 422: 226-32.
13. Gulmann C, Sheehan KM, Kay EW, et al. Array-based proteomis: mapping of protein circuitries for diagnostics, prognostics and therapy guidance in cancer. J Pathol. 2006; 208: 595-606.
14. Bantscheff M, Scholten A, Heck AJR. Revealing promiscuous drug-target interactions by chemical proteomics. Drug Discov Today. 2009; 14: 1021-9.
15. James WY, Sung WK, David AB. Women and heart disease-physiologic regulation of gene delivery and expression: bioreducible polymers and ischemia-inducible gene therapies for the treatment of ischemic heart disease. Adv Drug Deliver Rev. 2009; 61: 863-70.
16. st ed. London Biomed Central LTD; 2007.
17. Zhang XL, Wang JG, Wu ZZ. Primary proteomic study of several nature tongue coating. Chin J Tradit Med Sci Technol. 2008; 15: 241-4.
18. Blagoev B, Kratchmarova I, Ong SE, et al. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol. 2003; 21: 315-8.
19. Tan QX, Lv ZP, Zhong XL, et al. Preliminary study on change of serum proteome in liver stagnation syndrome. Liaoning J Tradit Chin Med. 2006; 33: 157-8.
20. Zhao HH, Wang W. Plasma proteomics study on unstable angina patients with blood stasis syndrome. Acta Chim Sinica. 2009; 67: 167-73.
21. Liu XC, Tian Z, Liu Y, et al. Comparative proteomic analysis of human Kidney-Yang deficiency syndrome serum. Chin J Biochem Molec Biol. 2007; 37: 592-9.
22. Qu JG, Lian QH, Chen J, et al. Human peripheral blood mononuclear cell proteome analysis of Parkinson disease with different TCM syndromes. Chin J Inform on Tradit Chin Med. 2008; 15: 10-3.
23. Wu HJ, Ma ZC, Gao Y, et al. Study on GAP in blood-stasis type of coronary heart disease by using proteomic technique. Chin J Integr Med on Cardio-Cerebrovascul Disease. 2005; 3: 189-91.
24. Hu XJ, Cai GX, Liu BY, et al. Proteomics study of the small intestinal epithelia of splenic asthenia syndrome mice and the adjust action of dry radix ginseng. Chin J Integr Tradit West Med Digest. 2008; 16: 351-4.
25. Xie WG, Ma XC, Shao NS, et al. Preliminary study on change of serum proteome in Noxious Blood Stasis Syndrome treated by radix paeoniae rubra. Chin J Integr Tradit West Med. 2005; 25: 520-4.
26. Wu J, Wang LX, Ying BY, et al. Change of calreticulin precursor in pulmonary hypertension rats interfered with puerarin. Chin J Clinic Pharmacol Therap. 2009; 14: 14-9.
27. Zhou J, Li CH, Huo HR, et al. Preliminary study on the changes of hypothalamic proteome caused by Gui-zhi Tang in fever rats. Chin J Exp Trad Med Formul. 2003; 9: 31-4.
28. Hu XJ, Cai GX, Liu BY, et al. Proteomics study of the small intestinal epithelia of splenic asthenia syndrome mice and the adjustive action of dry radix ginseng. Chin J Integr Tradit West Med Digest. 2008; 16: 351-4.
29. Zhang Y, Chen ZQ, Zhong GW. Effect of therapy of soothing liver and subsiding Yang on hypothalamic protein expression in hypertensive rats. J Guangzhou Univ Tradit Chin Med. 2008; 25: 325-31.
30. Yang YM, Zahng Q, Liu FM, et al. Comparing the action of the microarray expression analysis identified several key protein candidates as the potential mediators of total flavones of hippophae rhamnoides L. and choerospondias axillaries fructus on myocardial protection. J Med Pharm Chin Minorit. 2008; 6: 52-4.
31. Tang FQ, Tian DF, Gong ZJ, et al. An investigation on the proteomics of nasopharyngeal carcinoma cell line HNEI treated with Qi-boosting toxin-resolving granule. Chin J Otorhinoaryn Integr Trad West Med. 2004; 12: 120-3.